Dominik Ellenrieder, Chairman, has been a medtech entrepreneur since 2001 active in different medtech segments. In 2000, he co-founded Kuros Therapeutics AG that was sold in 2002. In 2001, he joined Medartis AG as a shareholder and vice-chairman. In 2003 he joined the board of Sentec AG and bought the major shareholders out in 2006. In 2009, he co-founded QGel SA. He also acts as chairman of Sentec AG and QGel SA and as vice-chairman of Medartis Holding AG and Kuros Biosciences AG. Furthermore he is also active as a venture partner of Endeavour Vision in Geneva since 2007.
businesses